NCT02068586
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02068586
Title Adjuvant Sunitinib or Valproic Acid in High-Risk Patients With Uveal Melanoma
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
Indications
Therapies
Age Groups: adult
Covered Countries USA


No variant requirements are available.